Page 68 - Sohini Das

Our goal is to have HPV vaccination as part of State mission: MSD India MD

In a Q&A, Rehan A Khan talks about his firm's strong focus on R&D and its commitment to making drugs affordable

CBI arrests Jt Drug Controller, Biocon Biologics execs over fishy approvals

All five apprehended will be presented in court on Tuesday afternoon, agency to seek police custody

SEC recommendation in accordance with guidelines: Biocon Biologics

The company said its product approvals are backed by science and clinical data

Fewer deaths, more hospitalisations in metros amid the spike in cases

Large cities are seeing an increase in occupancy, though most beds still remain vacant

Bharat Biotech's Covaxin induces wider immune response, say experts

However, experts say that Covaxin induces a wider immune response and thus antibody production against the spike protein may be less intense

Covishield booster post Covaxin priming improves immune response 58x: CMC

So far, India has not allowed heterologous boosting of vaccines

Price rationalisation, consolidation likely in Indian diagnostic space

Competitive pricing, however, is here to stay, feel analysts and some industry insiders

WTO's vaccine patent waiver may have little impact on ground now: Industry

Serum Institute says while patent waivers for Covid-19 vaccines are 'encouraging', demand for vaccines today is declining

Bharat Biotech's Covaxin is safe for children between 2 and 18 yrs: Lancet

Data from over 50 million doses reveals minimal side effects

Glenmark drug for treating uncontrolled asthma gets Indian regulator's nod

Company says treatment will be affordable and improve lung function of patients

Top 300 drug brands to have QR codes on label for ensuring authenticity

The Union Ministry of Health has made amendments to the Drugs Rules, 1945, to implement this

Vaccine makers claims efficacy against Omicron variant of Covid-19

Omicron has been the dominant strain across the world since January, quickly replacing the Delta variant that had caused a devastating second wave in India

Lots of interest in Metropolis, but we want a strategic fit: MD Ameera Shah

In a Q&A, the promoter and MD of the company talks about how the dynamics are changing in the diagnostics sector post Covid, and outlines her strategy for Metropolis 3.0

No plans to exit business, says Metropolis Healthcare promoters

"The company, its promoters and management team are committed to operating Metropolis Healthcare Ltd with the highest standards of medical science, stakeholder trust and customer engagement," the comp

No plans to exit business, clarify Metropolis Healthcare promoters

Metropolis Healthcare is continuously exploring various strategic options and investment

Corbevax gets approval as heterogenous vax, but isn't listed on CoWin

Company had issued a press release on June 4 where it said DCGI has approved Corbevax as a heterologous Covid booster dose to individuals aged 18 and above after 6 months of primary vaccination

Hundreds of millions of Covid vaccines in India to expire in September

Covaxin has a shelf life of 12 months, while Covishield, the vaccine that accounted for nearly 80% of India's vaccinations, has a shelf life of nine months

Gene therapy to cure leukemia at one-tenth global costs in the works

ImmunoACT, backed by Laurus Labs is testing their cancer product

Mumbai amps up hospital capacity and stocks medicines as Covid cases rise

Occupancy has more than doubled over the last week

Covid-19 testing drops even as daily cases rise to three-month high

Testing volumes have not grown much nationally, though individual states show some improvement